Eleftherios P. Mamounas, Ming Chen, Joseph A. Sparano, Md Ashequr Rahman, Yating Cheng, Victoria Wang, Robert J. Gray, Priya Rastogi, Eghbal Amidi, Charles E. Geyer, Tommy Boucher, Tanner J. Freeman, Mohammadreza Ramzanpour, Mukund Varma, Hassan Ghani, Caleb Cheng, Casey Bales, Jennifer R. Ribeiro, Hanna Bandos, Nicolas Stransky, Mark R. Miglarese, Matthew J. Oberley, David Spetzler, Milan Radovich, George W. Sledge, Norman Wolmark
Kaplan–Meier analysis of DR comparing patients treated with ELT vs. placebo in the NSABP B-42 translational cohort. A, All patients. B, Low-risk group. C, High-risk group. High- and low-risk groups are defined by the M3T model.